Your browser doesn't support javascript.
loading
NC-6004 Phase I study in combination with gemcitabine for advanced solid tumors and population PK/PD analysis.
Doi, Toshihiko; Hamaguchi, Tetsuya; Shitara, Kohei; Iwasa, Satoru; Shimada, Yasuhiro; Harada, Mitsunori; Naito, Kenichiro; Hayashi, Naoto; Masada, Atsuhiro; Ohtsu, Atsushi.
Afiliação
  • Doi T; Exploratory Oncology Research and Clinical Trial Center, National Cancer Center Hospital East, Chiba, Japan.
  • Hamaguchi T; Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan.
  • Shitara K; Exploratory Oncology Research and Clinical Trial Center, National Cancer Center Hospital East, Chiba, Japan.
  • Iwasa S; Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan.
  • Shimada Y; Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan.
  • Harada M; NanoCarrier Co. Ltd., Onoya Kyobashi Building, 1-4-10 Kyobashi, Chuo-ku, Tokyo, 104-0031, Japan.
  • Naito K; NanoCarrier Co. Ltd., Onoya Kyobashi Building, 1-4-10 Kyobashi, Chuo-ku, Tokyo, 104-0031, Japan.
  • Hayashi N; NanoCarrier Co. Ltd., Onoya Kyobashi Building, 1-4-10 Kyobashi, Chuo-ku, Tokyo, 104-0031, Japan.
  • Masada A; NanoCarrier Co. Ltd., Onoya Kyobashi Building, 1-4-10 Kyobashi, Chuo-ku, Tokyo, 104-0031, Japan. masada@nanocarrier.co.jp.
  • Ohtsu A; Exploratory Oncology Research and Clinical Trial Center, National Cancer Center Hospital East, Chiba, Japan.
Cancer Chemother Pharmacol ; 79(3): 569-578, 2017 03.
Article em En | MEDLINE | ID: mdl-28224231

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão